NantHealth lost $184 million in 2016 as struggles plague Soon-Shiong’s cancer tech
Lack of sales from its GPC Cancer diagnostic test dragged down finances as the company continues to face public scrutiny.
Powered by WPeMatico
Lack of sales from its GPC Cancer diagnostic test dragged down finances as the company continues to face public scrutiny.
Powered by WPeMatico